Gene784
CACNB3: calcium voltage-gated channel auxiliary subunit beta 3
Cite this record
ConductScience Library. CACNB3: calcium voltage-gated channel auxiliary subunit beta 3. Genes, record 784. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/784
- Drug
- PREGABALIN515 trials
- Disease
- alcohol dependence125 drugs
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Connected records115
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Drugs and targets11
- PREGABALINActs on it, modulator515 trials, 152 with posted results
- GABAPENTINActs on it, modulator425 trials, 127 with posted results
- GABAPENTIN ENACARBILActs on it, modulator34 trials, 17 with posted results
- IMAGABALINActs on it, modulator14 trials, 0 with posted results
- ATAGABALINActs on it, modulator5 trials, 0 with posted results
- PHLOROGLUCINOLActs on it, blocker5 trials, 0 with posted results
- BEPRIDILActs on it, blockerNo trials
- BEPRIDIL HYDROCHLORIDEActs on it, blockerNo trials
- SULOCTIDILActs on it, blockerNo trials
- TERODILINEActs on it, blockerNo trials
- TERODILINE HYDROCHLORIDEActs on it, blockerNo trials
Diseases20 of 104
- alcohol dependence3 of its drugs act on it125 drugs, 317 trials
- neuropathic pain3 of its drugs act on it154 drugs, 225 trials
- restless legs syndrome3 of its drugs act on it47 drugs, 107 trials
- postherpetic neuralgia3 of its drugs act on it53 drugs, 85 trials
- Sleep disturbance3 of its drugs act on it41 drugs, 57 trials
- neuralgia3 of its drugs act on it10 drugs, 4 trials
- breast cancer2 of its drugs act on it1,032 drugs, 4,781 trials
- major depressive disorder2 of its drugs act on it472 drugs, 1,484 trials
- Pain2 of its drugs act on it508 drugs, 1,080 trials
- multiple sclerosis symptom measurement2 of its drugs act on it279 drugs, 877 trials
- depressive disorder2 of its drugs act on it301 drugs, 599 trials
- overactive bladder2 of its drugs act on it75 drugs, 303 trials
- insomnia2 of its drugs act on it118 drugs, 287 trials
- epilepsy2 of its drugs act on it139 drugs, 240 trials
- cardiovascular disorder2 of its drugs act on it522 drugs, 218 trials
- anxiety2 of its drugs act on it155 drugs, 209 trials
- cocaine dependence2 of its drugs act on it105 drugs, 192 trials
- fibromyalgia2 of its drugs act on it103 drugs, 180 trials
- opioid use disorder2 of its drugs act on it64 drugs, 157 trials
- Low back pain2 of its drugs act on it117 drugs, 156 trials
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P54284 | Voltage-dependent L-type calcium channel subunit beta-3 | 484 | 16 | Ensembl, GeneID, HGNC |
Source UniProt
Patents104
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260337666 A1 | 2026-10-29 | 25568 | P54284 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 3614 | P54284 | Espacenet |
| US 12577609 B2 | 2026-03-17 | 25568 | P54284 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 39601 | P54284 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3614 | P54284 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3614 | P54284 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 10678 | P54284 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 1508 | P54284 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 25568 | P54284 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 1508 | P54284 | Espacenet |
Drugs11
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action | Source |
|---|---|---|---|---|
| ATAGABALIN | CHEMBL593430 | Voltage-gated calcium channel modulator | MODULATOR | ChEMBL |
| BEPRIDIL | CHEMBL1008 | Voltage-gated calcium channel blocker | BLOCKER | ChEMBL |
| BEPRIDIL HYDROCHLORIDE | CHEMBL1200382 | Voltage-gated calcium channel blocker | BLOCKER | ChEMBL |
| GABAPENTIN | CHEMBL940 | Voltage-gated calcium channel modulator | MODULATOR | ChEMBL |
| GABAPENTIN ENACARBIL | CHEMBL1628502 | Voltage-gated calcium channel modulator | MODULATOR | ChEMBL |
| IMAGABALIN | CHEMBL2103836 | Voltage-gated calcium channel modulator | MODULATOR | ChEMBL |
| PHLOROGLUCINOL | CHEMBL473159 | Voltage-gated calcium channel blocker | BLOCKER | ChEMBL |
| PREGABALIN | CHEMBL1059 | Voltage-gated calcium channel modulator | MODULATOR | ChEMBL |
| SULOCTIDIL | CHEMBL404849 | Voltage-gated calcium channel blocker | BLOCKER | ChEMBL |
| TERODILINE | CHEMBL363295 | Voltage-gated calcium channel blocker | BLOCKER | ChEMBL |
Trials370
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07606638 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07598474 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07429734 | GABAPENTIN | PHASE3 | ClinicalTrials.gov | |
| NCT07382921 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07344467 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07230197 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07230171 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07208357 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07196657 | PREGABALIN | ClinicalTrials.gov | ||
| NCT07186751 | PREGABALIN | ClinicalTrials.gov |
NIH grants363
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CACNB3 papers | Newest fiscal year |
|---|---|---|---|
| P30EY016665 | Core Grant for Vision Research | 2 | 2025 |
| R01AI042347 | Host-pathogen interactions in experimental cholera | 2 | 2025 |
| T32AI007520 | Molecular Microbiology Training Grant | 2 | 2025 |
| DP1DA054394 | Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction | 1 | 2025 |
| K01DK129404 | Unraveling the role of osteocytes in metabolic dysfunction associated with obesity | 1 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 1 | 2025 |
| P01CA163227 | Androgen Receptor Action in Castration Resistant Prostate Cancer | 1 | 2025 |
| P30AG066444 | Alzheimer's Disease Research Center | 1 | 2025 |
| P30AG066509 | University of Washington Alzheimer's Disease Research Center | 1 | 2025 |
| P30AR073752 | Washington University Rheumatic Diseases Research Resource-based Center | 1 | 2025 |
Source NIH's project files
Papers307
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CACNB3 defects are associated with infantile idiopathic nystagmus. | Brain Commun | 2026 | 41822111 | PubTator, text mining | PubMed |
| The ER membrane protein complex acts as a chaperone to promote the biogenesis of multi-bundle membrane proteins. | bioRxiv | 2026 | 41648177 | PubTator, text mining | PubMed |
| Establishing synthetic ribbon-type active zones in a heterologous expression system. | Elife | 2026 | 41528127 | PubTator, text mining | PubMed |
| Proteomic Analysis Infers Optimized ATP-Production in Guard Cell Mitochondria. | Physiol Plant | 2025 | 40999960 | PubTator, text mining | PubMed |
| Development of machine learning models for diagnostic biomarker identification and immune cell infiltration analysis in PCOS. | J Ovarian Res | 2025 | 39754246 | PubTator, text mining | PubMed |
| Cavβ3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis. | Arterioscler Thromb Vasc Biol | 2024 | 38957986 | PubTator, text mining | PubMed |
| Utilizing genetics and proteomics to assess the role of antihypertensive drugs in human longevity and the underlying pathways: a Mendelian randomization study. | Eur Heart J Cardiovasc Pharmacother | 2024 | 38769606 | PubTator, text mining | PubMed |
| Genetic and immune determinants of E. coli liver abscess formation. | Proc Natl Acad Sci U S A | 2023 | 38096412 | PubTator, text mining | PubMed |
| Stroma-associated FSTL3 is a factor of calcium channel-derived tumor fibrosis. | Sci Rep | 2023 | 38044354 | PubTator, text mining | PubMed |
| A characteristic cerebellar biosignature for bipolar disorder, identified with fully automatic machine learning. | IBRO Neurosci Rep | 2023 | 38025660 | PubTator, text mining | PubMed |
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/784
GET https://conductscience.org/api/genes/v1/784/patents?page=2